OBJECTIVE: To systematically evaluate and synthesize published evidence regarding the effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care. STUDY DESIGN: Systematic literature review and meta-analysis. PATIENTS AND METHODS: Computerized databases were searched for English-language controlled studies assessing the effect of diabetes disease management programs published from 1987 to 2001. Two reviewers extracted study data using a structured abstraction form. Pooled estimates of program effects on glycated hemoglobin were calculated using an empirical Bayes model. RESULTS: The pooled estimate of program effects on glycated hemoglobin was a 0.5-percentage point reduction (95% confidence interval, 0.3 to 0.6 percentage points), a modest but significant improvement. Evidence also supports program benefits in improving screening for retinopathy and foot lesions. CONCLUSIONS: Diabetes disease management programs can improve glycemic control to a modest extent and can increase screening for retinopathy and foot complications. Further efforts will be required to create more effective disease management programs for patients with diabetes mellitus.
OBJECTIVE: To systematically evaluate and synthesize published evidence regarding the effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care. STUDY DESIGN: Systematic literature review and meta-analysis. PATIENTS AND METHODS: Computerized databases were searched for English-language controlled studies assessing the effect of diabetes disease management programs published from 1987 to 2001. Two reviewers extracted study data using a structured abstraction form. Pooled estimates of program effects on glycated hemoglobin were calculated using an empirical Bayes model. RESULTS: The pooled estimate of program effects on glycated hemoglobin was a 0.5-percentage point reduction (95% confidence interval, 0.3 to 0.6 percentage points), a modest but significant improvement. Evidence also supports program benefits in improving screening for retinopathy and foot lesions. CONCLUSIONS:Diabetes disease management programs can improve glycemic control to a modest extent and can increase screening for retinopathy and foot complications. Further efforts will be required to create more effective disease management programs for patients with diabetes mellitus.
Authors: Maria Flamm; Sigrid Panisch; Henrike Winkler; Tim Johansson; Raimund Weitgasser; Andreas C Sönnichsen Journal: Wien Klin Wochenschr Date: 2012-08-08 Impact factor: 1.704
Authors: Richard O White; Darren A DeWalt; Robert M Malone; Chandra Y Osborn; Michael P Pignone; Russell L Rothman Journal: Am J Manag Care Date: 2010-01 Impact factor: 2.229
Authors: David J T Campbell; Peter Sargious; Richard Lewanczuk; Kerry McBrien; Marcello Tonelli; Brenda Hemmelgarn; Braden Manns Journal: Can Fam Physician Date: 2013-02 Impact factor: 3.275
Authors: Zhehui Luo; Qiaoling Chen; Ann M Annis; Gretchen Piatt; Lee A Green; Min Tao; Jodi Summers Holtrop Journal: J Gen Intern Med Date: 2016-03-07 Impact factor: 5.128
Authors: Jun Ma; Kathy Berra; William L Haskell; Linda Klieman; Shauna Hyde; Mark W Smith; Lan Xiao; Randall S Stafford Journal: Arch Intern Med Date: 2009-11-23
Authors: Martha M Funnell; Tammy L Brown; Belinda P Childs; Linda B Haas; Gwen M Hosey; Brian Jensen; Melinda Maryniuk; Mark Peyrot; John D Piette; Diane Reader; Linda M Siminerio; Katie Weinger; Michael A Weiss Journal: Diabetes Care Date: 2010-01 Impact factor: 19.112